April 28th
The news of "30 years of data fraud in gastrointestinal medicine Zhenglu pills".
aroused widespread attention from netizens
This is the successor of the Japanese pharmaceutical company Kobayashi Pharmaceutical
After an accident with a health supplement containing red yeast rice
Another Internet celebrity drug "thunder"
Data fraud for more than 30 years!
The production company was ordered to close down
According to Japanese media reports on the 27th, Japan's Far Eastern Company, the manufacturer of the well-known gastrointestinal drug "Zhenglu Pill", was exposed to tampering with the test data of the drug for more than 30 consecutive years due to insufficient production ingredients.
Japan's Far East Company's well-known product is Zhenglu Pill. Source: Screenshot of the official website of Japan's Far East Company
The report quoted a report from the Toyama Prefecture government, where Jidong is located, that during a sudden inspection, the active ingredient in the drug was found to be seriously inconsistent with the advertised efficacy, and that Jidong had been tampering with experimental data for the past 30 years in order to conceal the truth, so that Zhenglu pills could pass the review and be marketed.
In addition to falsifying data, four gastrointestinal medicines, including "Zhenglu Pill" produced by Jidong, were also found to have violated laws and regulations by directly using the test data of the manufacturer of raw materials without conducting quality tests when procuring raw materials.
According to the report, on April 16, local time, the Toyama County Government of Japan has ordered the Far East Company to suspend business in accordance with Japan's "Pharmaceutical and Medical Device Law". The business closure order will take effect from April 30, stopping the manufacture of pharmaceuticals in the Far East for 23 days and stopping the sale of drugs for 22 days. At the same time, it is required to submit a plan for measures and improvements to prevent recurrence within one month from the 26th.
In the face of doubts from the public and related parties, Jidong admitted that it had been tampering with drug trial results since 30 years ago, and apologized for its lack of awareness of compliance with regulations. "The company is committed to taking this incident seriously, working to restore consumer trust, and thoroughly investigate to prevent similar incidents from happening again.
So far, the company has independently recalled 5.16 million copies of Zhenglu pills that went to the market. It has been reported that there are no cases of people in Toyama Prefecture suffering from health damage.
It used to be a common medicine in many people's homes
Netizen: "No wonder it doesn't work after eating"
It is understood that Zhenglu Pill is a gastrointestinal Chinese patent medicine produced in Japan, and the products sell well in Japan, China and Southeast Asia. The brands with large sales volume include the "Horn Brand Zhenglu Pill" of Japan's Daiko Pharmaceutical Company and the "Jidong Brand Zhenglu Pill" of the company involved, which are regarded by many people as a standing medicine at home and can be described as a "national gastrointestinal medicine".
Domestic consumers are no strangers to this, social platforms show that Zhenglu pills are popular with many consumers, and many people say that they have seen promotional advertisements and social media sharing before, and they used to be a standing medicine at home.
Some netizens expressed their shock, "No wonder taking this medicine has no effect";
There are also many netizens who said, "I often have this medicine at home."
Another Japanese pharmaceutical company, Kobayashi Pharmaceutical, also "exploded"
As a result, five people died and hundreds were hospitalized
It is reported that this is the second scandal of Japanese pharmaceutical companies after the "red yeast rice turmoil" of Kobayashi Pharmaceutical this year. According to previous reports, the health care products containing red yeast rice ingredients produced by Kobayashi Pharmaceutical, a well-known Japanese pharmaceutical company, caused an uproar in the event of damage to consumers' health. As of April 24, five consumers had died and 257 were hospitalized among consumers who had taken the company's health products.
According to the results of the survey released on April 11, most of the people who have health damage problems after taking Kobayashi Pharmaceutical health products have a disease caused by abnormal renal tubular function - Fanconi syndrome.
Source: Guangzhou Daily (guangzhoudaily) Comprehensive Global Times, Kankan News, China News Network
Editor: Little W